Abstract
Data sources: International Agency for Research on Cancer Monographs; California and US Environmental Protection Agency cancer potency factors (CPFs) and reference exposure levels; scientific journals and government reports from the USA, Canada, and New Zealand.
Study selection: This was an inclusive review of studies reporting yields of cigarette smoke constituents using standard ISO methods.
Data extraction: Where possible, the midpoint of reported ranges of yields was used.
Data synthesis: Data on 158 compounds in cigarette smoke were found. Of these, 45 were known or suspected human carcinogens. Cancer potency factors were available for 40 of these compounds and reference exposure levels (RELs) for non-cancer effects were found for 17. A cancer risk index (CRI) was calculated by multiplying yield levels with CPFs. A non-cancer risk index (NCRI) was calculated by dividing yield levels with RELs. Gas phase constituents dominate both CRI and NCRI for cigarette smoke. The contribution of 1,3-butadiene (BDE) to CRI was more than twice that of the next highest contributing carcinogen (acrylonitrile) using potencies from the State of California EPA. Using those potencies from the USEPA, BDE ranked third behind arsenic and acetaldehyde. A comparison of CRI estimates with estimates of smoking related cancer deaths in the USA showed that the CRI underestimates the observed cancer rates by about fivefold using ISO yields in the exposure estimate.
Conclusions: The application of toxicological risk assessment methods to cigarette smoke provides a plausible and objective framework for the prioritisation of carcinogens and other toxicant hazards in cigarette smoke. However, this framework does not enable the prediction of actual cancer risk for a number of reasons that are discussed. Further, the lack of toxicology data on cardiovascular end points for specific chemicals makes the use of this framework less useful for cardiovascular toxicity. The bases for these priorities need to be constantly re-evaluated as new toxicology information emerges.
Full Text
The Full Text of this article is available as a PDF (322.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Benowitz N. L., Hall S. M., Herning R. I., Jacob P., 3rd, Jones R. T., Osman A. L. Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med. 1983 Jul 21;309(3):139–142. doi: 10.1056/NEJM198307213090303. [DOI] [PubMed] [Google Scholar]
- Borgerding M. F., Bodnar J. A., Chung H. L., Mangan P. P., Morrison C. C., Risner C. H., Rogers J. C., Simmons D. F., Uhrig M. S., Wendelboe F. N. Chemical and biological studies of a new cigarette that primarily heats tobacco. Part 1. Chemical composition of mainstream smoke. Food Chem Toxicol. 1998 Jul;36(7):169–182. [PubMed] [Google Scholar]
- Daisey J. M., Mahanama K. R., Hodgson A. T. Toxic volatile organic compounds in simulated environmental tobacco smoke: emission factors for exposure assessment. J Expo Anal Environ Epidemiol. 1998 Jul-Sep;8(3):313–334. [PubMed] [Google Scholar]
- Dybing E., Søderlund E. J., Gordon W. P., Holme J. A., Christensen T., Becher G., Rivedal E., Thorgeirsson S. S. Studies on the mechanism of acetamide hepatocarcinogenicity. Pharmacol Toxicol. 1987 Jan;60(1):9–16. doi: 10.1111/j.1600-0773.1987.tb01712.x. [DOI] [PubMed] [Google Scholar]
- Fischer S., Spiegelhalder B., Eisenbarth J., Preussmann R. Investigations on the origin of tobacco-specific nitrosamines in mainstream smoke of cigarettes. Carcinogenesis. 1990 May;11(5):723–730. doi: 10.1093/carcin/11.5.723. [DOI] [PubMed] [Google Scholar]
- Hecht S. S. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res. 1999 Mar 8;424(1-2):127–142. doi: 10.1016/s0027-5107(99)00014-7. [DOI] [PubMed] [Google Scholar]
- Löfroth G., Zebühr Y. Polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) in mainstream and sidestream cigarette smoke. Bull Environ Contam Toxicol. 1992 Jun;48(6):789–794. doi: 10.1007/BF00201136. [DOI] [PubMed] [Google Scholar]
- Mitacek E. J., Brunnemann K. D., Hoffmann D., Limsila T., Suttajit M., Martin N., Caplan L. S. Volatile nitrosamines and tobacco-specific nitrosamines in the smoke of Thai cigarettes: a risk factor for lung cancer and a suspected risk factor for liver cancer in Thailand. Carcinogenesis. 1999 Jan;20(1):133–137. doi: 10.1093/carcin/20.1.133. [DOI] [PubMed] [Google Scholar]
- Rustemeier K., Stabbert R., Haussmann H. J., Roemer E., Carmines E. L. Evaluation of the potential effects of ingredients added to cigarettes. Part 2: chemical composition of mainstream smoke. Food Chem Toxicol. 2002 Jan;40(1):93–104. doi: 10.1016/s0278-6915(01)00085-0. [DOI] [PubMed] [Google Scholar]
- Shopland D. R. Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking. Environ Health Perspect. 1995 Nov;103 (Suppl 8):131–142. doi: 10.1289/ehp.95103s8131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith C. J., Livingston S. D., Doolittle D. J. An international literature survey of "IARC Group I carcinogens" reported in mainstream cigarette smoke. Food Chem Toxicol. 1997 Oct-Nov;35(10-11):1107–1130. doi: 10.1016/s0278-6915(97)00063-x. [DOI] [PubMed] [Google Scholar]
- van Sittert N. J., Megens H. J., Watson W. P., Boogaard P. J. Biomarkers of exposure to 1,3-butadiene as a basis for cancer risk assessment. Toxicol Sci. 2000 Jul;56(1):189–202. doi: 10.1093/toxsci/56.1.189. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.